---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-021085"
form_type: "8-K"
ticker: "IBO"
cik: "0001834105"
company_name: "IMPACT BIOMEDICAL INC."
filed_at: "2025-07-28T23:59:59+00:00"
generated_at: "2026-05-18T00:23:56.884348+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Impact BioMedical to issue 31.9M shares to DSS to settle $12M debt

## Summary
- Issued 31,939,778 shares of common stock to DSS Inc. to fully satisfy $12M revolving promissory note from March 2023.
- Original note was amended Jan 2024 to extend maturity to Sept 30, 2023, eliminate advance feature, set repayment terms, adjust interest to WSJ Prime + 0.5%.
- Shares are freely tradeable and settle all amounts owed under the note and any additional support between June 21, 2025 and closing.

## SEC filing metadata
- accession: 0001641172-25-021085
- form_type: 8-K
- ticker: IBO
- cik: 0001834105
- company_name: IMPACT BIOMEDICAL INC.
- filed_at: 2025-07-28T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1834105/000164117225021085/0001641172-25-021085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1834105/000164117225021085/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-021085
- JSON: https://secwatch.observer/filing/0001641172-25-021085.json
- Plain text: https://secwatch.observer/filing/0001641172-25-021085.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.